7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Nabipour I et al. | Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatory. | 2009 Sep-Oct | Menopause | pmid:19387415 |
| Pineda B et al. | Effects of administration of hormone therapy or raloxifene on the immune system and on biochemical markers of bone remodeling. | 2012 | Menopause | pmid:22067277 |
| Lee HJ et al. | Association between polymorphisms in leptin, leptin receptor, and β-adrenergic receptor genes and bone mineral density in postmenopausal Korean women. | 2014 | Menopause | pmid:23760429 |
| Prezelj J et al. | Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17882010 |
| Kim JG et al. | Changes in the serum levels of osteoprotegerin and soluble receptor activator for nuclear factor kappaB ligand after estrogen-progestogen therapy and their relationships with changes in bone mass in postmenopausal women. | 2008 Mar-Apr | Menopause | pmid:17925661 |
| Kim H et al. | Association between Wnt signaling pathway gene polymorphisms and bone response to hormone therapy in postmenopausal Korean women. | 2011 | Menopause | pmid:21471826 |
| Reyes-GarcÃa R et al. | Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis. | 2010 Jan-Feb | Menopause | pmid:19574937 |
| Tyagi AM et al. | Formononetin reverses established osteopenia in adult ovariectomized rats. | 2012 | Menopause | pmid:22781783 |
| Zhang ZG et al. | Therapeutic effect of aqueous extract from Ecliptae herba on bone metabolism of ovariectomized rats. | 2013 | Menopause | pmid:23096243 |
| McClung MR | Looking for answers in all the wrong places. | 2007 Jan-Feb | Menopause | pmid:17194959 |
| Kim JG et al. | Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. | 2007 Sep-Oct | Menopause | pmid:17667143 |
| Oh ES et al. | Circulating osteoprotegerin levels are associated with age, waist-to-hip ratio, serum total cholesterol, and low-density lipoprotein cholesterol levels in healthy Korean women. | 2005 | Metab. Clin. Exp. | pmid:15562379 |
| Nabipour I et al. | Osteoprotegerin in relation to type 2 diabetes mellitus and the metabolic syndrome in postmenopausal women. | 2010 | Metab. Clin. Exp. | pmid:19922962 |
| Ostergård T et al. | Endothelial function and biochemical vascular markers in first-degree relatives of type 2 diabetic patients: the effect of exercise training. | 2006 | Metab. Clin. Exp. | pmid:17046554 |
| O'Sullivan EP et al. | A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. | 2013 | Metab. Clin. Exp. | pmid:22841521 |
| Siepi D et al. | Preclinical vascular damage in white postmenopausal women: the relevance of osteoprotegerin. | 2008 | Metab. Clin. Exp. | pmid:18249202 |
| Maïmoun L et al. | Peripubertal female athletes in high-impact sports show improved bone mass acquisition and bone geometry. | 2013 | Metab. Clin. Exp. | pmid:23490587 |
| Ashley DT et al. | Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects. | 2011 | Metab. Clin. Exp. | pmid:21087777 |
| Wieczorek-Baranowska A et al. | Osteocalcin and glucose metabolism in postmenopausal women subjected to aerobic training program for 8 weeks. | 2012 | Metab. Clin. Exp. | pmid:22000586 |
| Takemura M et al. | Relationship between osteoprotegerin/osteoclastogenesis inhibitory factor concentration in synovial fluid and disease severity in individuals with osteoarthritis of the knee. | 2001 | Metab. Clin. Exp. | pmid:11172466 |
| Giusti M et al. | Serum osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand levels in patients with a history of differentiated thyroid carcinoma: a case-controlled cohort study. | 2007 | Metab. Clin. Exp. | pmid:17445547 |
| Chang YH et al. | Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy. | 2011 | Metab. Clin. Exp. | pmid:21251686 |
| Ziegler S et al. | Endurance running acutely raises plasma osteoprotegerin and lowers plasma receptor activator of nuclear factor kappa B ligand. | 2005 | Metab. Clin. Exp. | pmid:15988704 |
| Krause U et al. | Assays of osteogenic differentiation by cultured human mesenchymal stem cells. | 2011 | Methods Mol. Biol. | pmid:21431522 |
| Nimmanapalli R and Bhalla K | Targets in apoptosis signaling: promise of selective anticancer therapy. | 2003 | Methods Mol. Biol. | pmid:12777745 |
| Belibasakis GN et al. | Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells. | 2011 | Microb. Pathog. | pmid:21075196 |
| Belibasakis GN et al. | Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis: a putative role of the Arg-gingipains. | 2007 | Microb. Pathog. | pmid:17448630 |
| Reddi D et al. | Porphyromonas gingivalis regulates the RANKL-OPG system in bone marrow stromal cells. | 2008 Nov-Dec | Microbes Infect. | pmid:18789397 |
| Sasaki T | Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. | 2003 | Microsc. Res. Tech. | pmid:12879416 |
| Helfrich MH | Osteoclast diseases. | 2003 | Microsc. Res. Tech. | pmid:12879419 |
| Kobayashi-Sakamoto M et al. | Role of alphav integrin in osteoprotegerin-induced endothelial cell migration and proliferation. | 2008 | Microvasc. Res. | pmid:18656492 |
| Aydin H et al. | Effect of oxidative stress on aorta and tibia osteoprotegerin gene expression in ovariectomized rats. | 2011 | Minerva Endocrinol. | pmid:21519319 |
| Mirzaei K et al. | Potential role of OPG/RANKL system and FokI genotypes in pathogenesis and clinical manifestations in multiple sclerosis. | 2012 | Minerva Med. | pmid:22805623 |
| Asanuma YF et al. | Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. | 2013 | Mod Rheumatol | pmid:22584471 |
| Tanishima S et al. | Minodronic acid influences receptor activator of nuclear factor kappaB ligand expression and suppresses bone resorption by osteoclasts in rats with collagen-induced arthritis. | 2007 | Mod Rheumatol | pmid:17564774 |
| Wang Y et al. | A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level. | 2009 | Mol Cell Biomech | pmid:19496258 |
| Zheleznyak A et al. | Integrin α(v)β₃ as a PET imaging biomarker for osteoclast number in mouse models of negative and positive osteoclast regulation. | 2012 | Mol Imaging Biol | pmid:21853370 |
| Zhou QL et al. | Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. | 2016 | Mol Med Rep | pmid:27357904 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Ren H et al. | Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. | 2015 | Mol Med Rep | pmid:26398911 |
| Joo MK et al. | The effect of a proton pump inhibitor on bone metabolism in ovariectomized rats. | 2013 | Mol Med Rep | pmid:23426758 |
| Ye M et al. | Prednisone inhibits the focal adhesion kinase/receptor activator of NF-κB ligand/mitogen-activated protein kinase signaling pathway in rats with adriamycin-induced nephropathy. | 2015 | Mol Med Rep | pmid:26459042 |
| Ma Y et al. | Effects of brucine on bone metabolism in multiple myeloma. | 2012 | Mol Med Rep | pmid:22614932 |
| Xu F et al. | Adipocytes regulate the bone marrow microenvironment in a mouse model of obesity. | 2013 | Mol Med Rep | pmid:23835909 |
| Wei J et al. | Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats. | 2015 | Mol Med Rep | pmid:25891179 |
| Wang XF et al. | The role of the serum RANKL/OPG ratio in the healing of intertrochanteric fractures in elderly patients. | 2013 | Mol Med Rep | pmid:23440406 |
| Kuroyanagi G et al. | Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. | 2015 | Mol Med Rep | pmid:26044505 |
| Jia J et al. | Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells. | 2017 | Mol Med Rep | pmid:28260003 |
| Feng ZY et al. | Osteoprotegerin promotes the proliferation of chondrocytes and affects the expression of ADAMTS-5 and TIMP-4 through MEK/ERK signaling. | 2013 | Mol Med Rep | pmid:24126801 |
| Pei Z et al. | Effect of icariin on cell proliferation and the expression of bone resorption/formation-related markers in human periodontal ligament cells. | 2013 | Mol Med Rep | pmid:24065204 |
| Kainuma S et al. | Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. | 2016 | Mol Med Rep | pmid:26935864 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| He M et al. | Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. | 2016 | Mol Med Rep | pmid:27277157 |
| Crosley LK et al. | The single-nucleotide polymorphism (GPX4c718t) in the glutathione peroxidase 4 gene influences endothelial cell function: interaction with selenium and fatty acids. | 2013 | Mol Nutr Food Res | pmid:23934705 |
| Nash LA et al. | Rooibos flavonoids, orientin and luteolin, stimulate mineralization in human osteoblasts through the Wnt pathway. | 2015 | Mol Nutr Food Res | pmid:25488131 |
| Sänger N et al. | OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. | 2014 | Mol Oncol | pmid:24785095 |
| Jung YJ et al. | Tannerella forsythia GroEL induces inflammatory bone resorption and synergizes with interleukin-17. | 2017 | Mol Oral Microbiol | pmid:27484636 |
| Watkins M et al. | Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. | 2011 | Mol. Biol. Cell | pmid:21346198 |
| Pritzker LB et al. | The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival. | 2004 | Mol. Biol. Cell | pmid:15064358 |
| Hussien YM et al. | Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. | 2013 | Mol. Biol. Rep. | pmid:23271131 |
| Lee YH et al. | Associations between osteoprotegerin polymorphisms and bone mineral density: a meta-analysis. | 2010 | Mol. Biol. Rep. | pmid:19642016 |
| Xiao HL et al. | Oral administration activity determination of recombinant osteoprotegerin from silkworm larvae. | 2007 | Mol. Biotechnol. | pmid:17435284 |
| Weichhaus M et al. | Osteoprotegerin in breast cancer: beyond bone remodeling. | 2015 | Mol. Cancer | pmid:26054853 |
| Fujita K and Janz S | Attenuation of WNT signaling by DKK-1 and -2 regulates BMP2-induced osteoblast differentiation and expression of OPG, RANKL and M-CSF. | 2007 | Mol. Cancer | pmid:17971207 |
| Arrigoni C et al. | Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone metastases. | 2014 | Mol. Cancer | pmid:25335447 |
| Reid PE et al. | Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact. | 2009 | Mol. Cancer | pmid:19604388 |
| Chung ST et al. | Osteoprotegerin mediates tumor-promoting effects of Interleukin-1beta in breast cancer cells. | 2017 | Mol. Cancer | pmid:28143606 |
| Cao Y et al. | The osterix transcription factor down-regulates interleukin-1 alpha expression in mouse osteosarcoma cells. | 2008 | Mol. Cancer Res. | pmid:18234967 |
| Higgs JT et al. | Variants of Osteoprotegerin Lacking TRAIL Binding for Therapeutic Bone Remodeling in Osteolytic Malignancies. | 2015 | Mol. Cancer Res. | pmid:25636966 |
| Locklin RM et al. | Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis. | 2007 | Mol. Cancer Ther. | pmid:18065493 |
| Miller RE et al. | RANK ligand inhibition plus docetaxel improves survival and reduces tumor burden in a murine model of prostate cancer bone metastasis. | 2008 | Mol. Cancer Ther. | pmid:18606716 |
| Rani CS and MacDougall M | Dental cells express factors that regulate bone resorption. | 2000 | Mol. Cell Biol. Res. Commun. | pmid:10860862 |
| Yamaguchi M et al. | Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions. | 2008 | Mol. Cell. Biochem. | pmid:18327666 |
| Guo D et al. | Bone morphogenetic protein 4 (BMP4) is required for migration and invasion of breast cancer. | 2012 | Mol. Cell. Biochem. | pmid:22167620 |
| Osorio A et al. | Biochemical markers of vascular calcification in elderly hemodialysis patients. | 2013 | Mol. Cell. Biochem. | pmid:23124853 |
| Geoffroy V et al. | High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. | 2002 | Mol. Cell. Biol. | pmid:12167715 |
| Mizukami J et al. | Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. | 2002 | Mol. Cell. Biol. | pmid:11809792 |
| Subramaniam M et al. | TIEG1 null mouse-derived osteoblasts are defective in mineralization and in support of osteoclast differentiation in vitro. | 2005 | Mol. Cell. Biol. | pmid:15657444 |
| Wang Y et al. | LC, a novel estrone-rhein hybrid compound, concurrently stimulates osteoprotegerin and inhibits receptor activator of NF-κB ligand (RANKL) and interleukin-6 production by human osteoblastic cells. | 2011 | Mol. Cell. Endocrinol. | pmid:21291955 |
| Olesen M et al. | No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. | 2012 | Mol. Cell. Endocrinol. | pmid:22698523 |
| Kühn MC et al. | Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. | 2012 | Mol. Cell. Endocrinol. | pmid:22040599 |
| Tsubaki M et al. | Bisphosphonate- and statin-induced enhancement of OPG expression and inhibition of CD9, M-CSF, and RANKL expressions via inhibition of the Ras/MEK/ERK pathway and activation of p38MAPK in mouse bone marrow stromal cell line ST2. | 2012 | Mol. Cell. Endocrinol. | pmid:22579611 |
| Welldon KJ et al. | Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markers. | 2013 | Mol. Cell. Endocrinol. | pmid:23791847 |
| Ma Y et al. | Acetylcholine affects osteocytic MLO-Y4 cells via acetylcholine receptors. | 2014 | Mol. Cell. Endocrinol. | pmid:24508663 |
| Oostra DR et al. | Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. | 2015 | Mol. Cell. Endocrinol. | pmid:25575458 |
| Toffoli B et al. | Osteoprotegerin induces morphological and functional alterations in mouse pancreatic islets. | 2011 | Mol. Cell. Endocrinol. | pmid:20832449 |
| Gutiérrez-Rojas I et al. | Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. | 2013 | Mol. Cell. Endocrinol. | pmid:23178165 |
| Shin J et al. | Structure-function of the TNF receptor-like cysteine-rich domain of osteoprotegerin. | 2008 | Mol. Cells | pmid:18443424 |
| Kang HS et al. | Receptor activator of nuclear factor-kappaB is induced by a rottlerin-sensitive and p38 MAP kinase-dependent pathway during monocyte differentiation. | 2004 | Mol. Cells | pmid:15232218 |
| Naranjo-Suarez S et al. | Regulation of HIF-1α activity by overexpression of thioredoxin is independent of thioredoxin reductase status. | 2013 | Mol. Cells | pmid:23912593 |
| Wang N et al. | Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. | 2012 | Mol. Endocrinol. | pmid:22108801 |
| Spelsberg TC et al. | The actions and interactions of sex steroids and growth factors/cytokines on the skeleton. | 1999 | Mol. Endocrinol. | pmid:10379881 |
| Dey P et al. | Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3. | 2012 | Mol. Endocrinol. | pmid:23028063 |
| Yamada Y et al. | Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. | 2003 | Mol. Genet. Metab. | pmid:14680982 |
| Yen ML et al. | TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells. | 2008 | Mol. Immunol. | pmid:18206242 |
| Doschak MR et al. | Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. | 2009 Mar-Apr | Mol. Pharm. | pmid:19718808 |
| Lee JH et al. | Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. | 2010 | Mol. Pharmacol. | pmid:19828731 |
| Lee ZH et al. | Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB. | 2000 | Mol. Pharmacol. | pmid:11093794 |
| Bolon B et al. | Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis. | 2001 | Mol. Ther. | pmid:11237676 |
| Chanda D et al. | Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis. | 2008 | Mol. Ther. | pmid:18388919 |